Chapter 9 Regulation of Immune Function by G Protein-Coupled Receptors, Trimeric G Proteins, and RGS Proteins

Progress in Molecular Biology and Translational Science

Volumn 86, Issue C, 2009, Pages 249-298

  Cho, Hyeseon ^a   Kehrl, John H ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; HETEROTRIMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; RGS PROTEIN;

ANIMAL; CELL MOTION; CYTOLOGY; HUMAN; IMMUNE SYSTEM; IMMUNOLOGY; LYMPHOCYTE; REVIEW;

ANIMALS; CELL MOVEMENT; HETEROTRIMERIC GTP-BINDING PROTEINS; HUMANS; IMMUNE SYSTEM; LYMPHOCYTES; RECEPTORS, G-PROTEIN-COUPLED; RGS PROTEINS;

EID: 77957116003     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1877-1173(09)86009-2     Document Type: Review

References (277)

1. Neer E.J. Heterotrimeric G proteins: organizers of transmembrane signals. Cell 80 (1995) 249-257
2. Hamm H.E., and Gilchrist A. Heterotrimeric G proteins. Curr Opin Cell Biol 8 (1996) 189-196
3. Offermanns S., and Simon M.I. Organization of transmembrane signalling by heterotrimeric G proteins. Cancer Surv 27 (1996) 177-198
4. Downes G.B., and Gautam N. The G protein subunit gene families. Genomics 62 (1999) 544-552
5. Koelle M.R., and Horvitz H.R. EGL-10 regulates G protein signaling in the C. elegans nervous system and shares a conserved domain with many mammalian proteins. Cell 84 (1996) 115-125
6. Berman D.M., Wilkie T.M., and Gilman A.G. GAIP and RGS4 are GTPase-activating proteins for the Gi subfamily of G protein alpha subunits. Cell 86 (1996) 445-452
7. Druey K.M., Blumer K.J., Kang V.H., and Kehrl J.H. Inhibition of G-protein-mediated MAP kinase activation by a new mammalian gene family. Nature 379 (1996) 742-746
8. Zhong H., Wade S.M., Woolf P.J., Linderman J.J., Traynor J.R., and Neubig R.R. A spatial focusing model for G protein signals. Regulator of G protein signaling (RGS) protien-mediated kinetic scaffolding. J Biol Chem 278 (2003) 7278-7284
9. Benians A., Nobles M., Hosny S., and Tinker A. Regulators of G-protein signaling form a quaternary complex with the agonist, receptor, and G-protein. A novel explanation for the acceleration of signaling activation kinetics. J Biol Chem 280 (2005) 13383-13394
10. Regard J.B., Sato I.T., and Coughlin S.R. Anatomical profiling of G protein-coupled receptor expression. Cell 135 (2008) 561-571
11. Lusso P. HIV and the chemokine system: 10 years later. EMBO J 25 (2006) 447-456
12. Bromley S.K., Mempel T.R., and Luster A.D. Orchestrating the orchestrators: chemokines in control of T cell traffic. Nat Immunol 9 (2008) 970-980
13. Alvarez D., Vollmann E.H., and von Andrian U.H. Mechanisms and consequences of dendritic cell migration. Immunity 29 (2008) 325-342
14. Luther S.A., and Cyster J.G. Chemokines as regulators of T cell differentiation. Nat Immunol 2 (2001) 102-107
15. Schwab S.R., and Cyster J.G. Finding a way out: lymphocyte egress from lymphoid organs. Nat Immunol 8 (2007) 1295-1301
16. Rivera J., Proia R.L., and Olivera A. The alliance of sphingosine-1-phosphate and its receptors in immunity. Nat Rev Immunol 8 (2008) 753-763
17. Okada T., and Cyster J.G. CC chemokine receptor 7 contributes to Gi-dependent T cell motility in the lymph node. J Immunol 178 (2007) 2973-2978
18. Pham T.H., Okada T., Matloubian M., Lo C.G., and Cyster J.G. S1P1 receptor signaling overrides retention mediated by G alpha i-coupled receptors to promote T cell egress. Immunity 28 (2008) 122-133
19. Grigorova I.L., Schwab S.R., Phan T.G., Pham T.H., Okada T., and Cyster J.G. Cortical sinus probing, S1P1-dependent entry and flow-based capture of egressing T cells. Nat Immunol 10 (2009) 58-65
20. Cinamon G., Zachariah M.A., Lam O.M., Foss Jr. F.W., and Cyster J.G. Follicular shuttling of marginal zone B cells facilitates antigen transport. Nat Immunol 9 (2008) 54-62
21. Luster A.D., and Tager A.M. T-cell trafficking in asthma: lipid mediators grease the way. Nat Rev Immunol 4 (2004) 711-724
22. Huang R., Cioffi J., Kimberly R., Edberg J., and Mayer L. B cell differentiation factor-induced human B cell maturation: stimulation of intracellular calcium release. Cell Immunol 164 (1995) 227-233
23. Ramirez R., Carracedo J., Zamzami N., Castedo M., and Kroemer G. Pertussis toxin inhibits activation-induced cell death of human thymocytes, pre-B leukemia cells and monocytes. J Exp Med 180 (1994) 1147-1152
24. Manna P.P., and Frazier W.A. The mechanism of CD47-dependent killing of T cells: heterotrimeric Gi-dependent inhibition of protein kinase A. J Immunol 170 (2003) 3544-3553
25. Mazer B., Domenico J., Sawami H., and Gelfand E.W. Platelet-activating factor induces an increase in intracellular calcium and expression of regulatory genes in human B lymphoblastoid cells. J Immunol 146 (1991) 1914-1920
26. Brown S.L., Jala V.R., Raghuwanshi S.K., Nasser M.W., Haribabu B., and Richardson R.M. Activation and regulation of platelet-activating factor receptor: role of G(i) and G(q) in receptor-mediated chemotactic, cytotoxic, and cross-regulatory signals. J Immunol 177 (2006) 3242-3249
27. Molon B., Gri G., Bettella M., Gomez-Mouton C., Lanzavecchia A., Martinez A.C., et al. T cell costimulation by chemokine receptors. Nat Immunol 6 (2005) 465-471
28. Tian Y., Lee M.M., Yung L.Y., Allen R.A., Slocombe P.M., Twomey B.M., et al. Differential involvement of Galpha16 in CC chemokine-induced stimulation of phospholipase Cbeta, ERK, and chemotaxis. Cell Signal 20 (2008) 1179-1189
29. Rubic T., Lametschwandtner G., Jost S., Hinteregger S., Kund J., Carballido-Perrig N., et al. Triggering the succinate receptor GPR91 on dendritic cells enhances immunity. Nat Immunol 9 (2008) 1261-1269
30. Jutel M., Blaser K., and Akdis C.A. Histamine receptors in immune regulation and allergen-specific immunotherapy. Immunol Allergy Clin North Am 26 (2006) 245-259 vii
31. Jutel M., Watanabe T., Klunker S., Akdis M., Thomet O.A., Malolepszy J., et al. Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature 413 (2001) 420-425
32. Ma R.Z., Gao J., Meeker N.D., Fillmore P.D., Tung K.S., Watanabe T., et al. Identification of Bphs, an autoimmune disease locus, as histamine receptor H1. Science 297 (2002) 620-623
33. Noubade R., Milligan G., Zachary J.F., Blankenhorn E.P., del Rio R., Rincon M., et al. Histamine receptor H1 is required for TCR-mediated p38 MAPK activation and optimal IFN-gamma production in mice. J Clin Invest 117 (2007) 3507-3518
34. Kohm A.P., and Sanders V.M. Norepinephrine and beta 2-adrenergic receptor stimulation regulate CD4+ T and B lymphocyte function in vitro and in vivo. Pharmacol Rev 53 (2001) 487-525
35. Podojil J.R., Kin N.W., and Sanders V.M. CD86 and beta2-adrenergic receptor signaling pathways, respectively, increase Oct-2 and OCA-B expression and binding to the 3′-IgH enhancer in B cells. J Biol Chem 279 (2004) 23394-23404
36. Loza M.J., Foster S., Peters S.P., and Penn R.B. Beta-agonists modulate T-cell functions via direct actions on type 1 and type 2 cells. Blood 107 (2006) 2052-2060
37. Pongratz G., McAlees J.W., Conrad D.H., Erbe R.S., Haas K.M., and Sanders V.M. The level of IgE produced by a B cell is regulated by norepinephrine in a p38 MAPK- and CD23-dependent manner. J Immunol 177 (2006) 2926-2938
38. Betz M., and Fox B.S. Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J Immunol 146 (1991) 108-113
39. Snijdewint F.G., Kalinski P., Wierenga E.A., Bos J.D., and Kapsenberg M.L. Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. J Immunol 150 (1993) 5321-5329
40. Wu C.Y., Wang K., McDyer J.F., and Seder R.A. Prostaglandin E2 and dexamethasone inhibit IL-12 receptor expression and IL-12 responsiveness. J Immunol 161 (1998) 2723-2730
41. Ozegbe P., Foey A.D., Ahmed S., and Williams R.O. Impact of cAMP on the T-cell response to type II collagen. Immunology 111 (2004) 35-40
42. Nagamachi M., Sakata D., Kabashima K., Furuyashiki T., Murata T., Segi-Nishida E., et al. Facilitation of Th1-mediated immune response by prostaglandin E receptor EP1. J Exp Med 204 (2007) 2865-2874
43. Paliogianni F., Kincaid R.L., and Boumpas D.T. Prostaglandin E2 and other cyclic AMP elevating agents inhibit interleukin 2 gene transcription by counteracting calcineurin-dependent pathways. J Exp Med 178 (1993) 1813-1817
44. Fedyk E.R., and Phipps R.P. Prostaglandin E2 receptors of the EP2 and EP4 subtypes regulate activation and differentiation of mouse B lymphocytes to IgE-secreting cells. Proc Natl Acad Sci USA 93 (1996) 10978-10983
45. Roper R.L., Graf B., and Phipps R.P. Prostaglandin E2 and cAMP promote B lymphocyte class switching to IgG1. Immunol Lett 84 (2002) 191-198
46. Murn J., Alibert O., Wu N., Tendil S., and Gidrol X. Prostaglandin E2 regulates B cell proliferation through a candidate tumor suppressor, Ptger4. J Exp Med 205 (2008) 3091-3103
47. Ryzhov S., Goldstein A.E., Biaggioni I., and Feoktistov I. Cross-talk between G(s)- and G(q)-coupled pathways in regulation of interleukin-4 by A(2B) adenosine receptors in human mast cells. Mol Pharmacol 70 (2006) 727-735
48. Ohta A., and Sitkovsky M. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414 (2001) 916-920
49. Csoka B., Himer L., Selmeczy Z., Vizi E.S., Pacher P., Ledent C., et al. Adenosine A2A receptor activation inhibits T helper 1 and T helper 2 cell development and effector function. FASEB J 22 (2008) 3491-3499
50. Mills J.H., Thompson L.F., Mueller C., Waickman A.T., Jalkanen S., Niemela J., et al. CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 105 (2008) 9325-9330
51. Takedachi M., Qu D., Ebisuno Y., Oohara H., Joachims M.L., McGee S.T., et al. CD73-generated adenosine restricts lymphocyte migration into draining lymph nodes. J Immunol 180 (2008) 6288-6296
52. Tomayko M.M., Anderson S.M., Brayton C.E., Sadanand S., Steinel N.C., Behrens T.W., et al. Systematic comparison of gene expression between murine memory and naive B cells demonstrates that memory B cells have unique signaling capabilities. J Immunol 181 (2008) 27-38
53. Minguet S., Huber M., Rosenkranz L., Schamel W.W., Reth M., and Brummer T. Adenosine and cAMP are potent inhibitors of the NF-kappa B pathway downstream of immunoreceptors. Eur J Immunol 35 (2005) 31-41
54. Gessi S., Varani K., Merighi S., Fogli E., Sacchetto V., Benini A., et al. Adenosine and lymphocyte regulation. Purinergic Signal 3 (2007) 109-116
55. Teuscher C., Poynter M.E., Offner H., Zamora A., Watanabe T., Fillmore P.D., et al. Attenuation of Th1 effector cell responses and susceptibility to experimental allergic encephalomyelitis in histamine H2 receptor knockout mice is due to dysregulation of cytokine production by antigen-presenting cells. Am J Pathol 164 (2004) 883-892
56. Wang J.Q., Kon J., Mogi C., Tobo M., Damirin A., Sato K., et al. TDAG8 is a proton-sensing and psychosine-sensitive G-protein-coupled receptor. J Biol Chem 279 (2004) 45626-45633
57. Radu C.G., Nijagal A., McLaughlin J., Wang L., and Witte O.N. Differential proton sensitivity of related G protein-coupled receptors T cell death-associated gene 8 and G2A expressed in immune cells. Proc Natl Acad Sci USA 102 (2005) 1632-1637
58. Malone M.H., Wang Z., and Distelhorst C.W. The glucocorticoid-induced gene tdag8 encodes a pro-apoptotic G protein-coupled receptor whose activation promotes glucocorticoid-induced apoptosis. J Biol Chem 279 (2004) 52850-52859
59. Goetzl E.J., and Rosen H. Regulation of immunity by lysosphingolipids and their G protein-coupled receptors. J Clin Invest 114 (2004) 1531-1537
60. Goetzl E.J., Wang W., McGiffert C., Huang M.C., and Graler M.H. Sphingosine 1-phosphate and its G protein-coupled receptors constitute a multifunctional immunoregulatory system. J Cell Biochem 92 (2004) 1104-1114
61. Davis M.D., and Kehrl J.H. The influence of sphingosine-1-phosphate receptor signaling on lymphocyte trafficking: How a bioactive lipid mediator grew up from an "immature" vascular maturation factor to a "mature" mediator of lymphocyte behavior and function. Immunol Res 43 (2009) 187-197
62. Graler M.H., Grosse R., Kusch A., Kremmer E., Gudermann T., and Lipp M. The sphingosine 1-phosphate receptor S1P4 regulates cell shape and motility via coupling to Gi and G12/13. J Cell Biochem 89 (2003) 507-519
63. Wang W., Graeler M.H., and Goetzl E.J. Type 4 sphingosine 1-phosphate G protein-coupled receptor (S1P4) transduces S1P effects on T cell proliferation and cytokine secretion without signaling migration. FASEB J 19 (2005) 1731-1733
64. Aoki J., Inoue A., and Okudaira S. Two pathways for lysophosphatidic acid production. Biochim Biophys Acta 1781 (2008) 513-518
65. Wang L., Knudsen E., Jin Y., Gessani S., and Maghazachi A.A. Lysophospholipids and chemokines activate distinct signal transduction pathways in T helper 1 and T helper 2 cells. Cell Signal 16 (2004) 991-1000
66. Rieken S., Herroeder S., Sassmann A., Wallenwein B., Moers A., Offermanns S., et al. Lysophospholipids control integrin-dependent adhesion in splenic B cells through G(i) and G(12)/G(13) family G-proteins but not through G(q)/G(11). J Biol Chem 281 (2006) 36985-36992
67. Hu X., Haney N., Kropp D., Kabore A.F., Johnston J.B., and Gibson S.B. Lysophosphatidic acid (LPA) protects primary chronic lymphocytic leukemia cells from apoptosis through LPA receptor activation of the anti-apoptotic protein AKT/PKB. J Biol Chem 280 (2005) 9498-9508
68. Kanda H., Newton R., Klein R., Morita Y., Gunn M.D., and Rosen S.D. Autotaxin, an ectoenzyme that produces lysophosphatidic acid, promotes the entry of lymphocytes into secondary lymphoid organs. Nat Immunol 9 (2008) 415-423
69. Mari B., Guerin S., Far D.F., Breitmayer J.P., Belhacene N., Peyron J.F., et al. Thrombin and trypsin-induced Ca(2+) mobilization in human T cell lines through interaction with different protease-activated receptors. FASEB J 10 (1996) 309-316
70. Joyce D.E., Chen Y., Erger R.A., Koretzky G.A., and Lentz S.R. Functional interactions between the thrombin receptor and the T-cell antigen receptor in human T-cell lines. Blood 90 (1997) 1893-1901
71. Bar-Shavit R., Maoz M., Yongjun Y., Groysman M., Dekel I., and Katzav S. Signalling pathways induced by protease-activated receptors and integrins in T cells. Immunology 105 (2002) 35-46
72. Hansen K.K., Saifeddine M., and Hollenberg M.D. Tethered ligand-derived peptides of proteinase-activated receptor 3 (PAR3) activate PAR1 and PAR2 in Jurkat T cells. Immunology 112 (2004) 183-190
73. Chen D., Carpenter A., Abrahams J., Chambers R.C., Lechler R.I., McVey J.H., et al. Protease-activated receptor 1 activation is necessary for monocyte chemoattractant protein 1-dependent leukocyte recruitment in vivo. J Exp Med 205 (2008) 1739-1746
74. Kabashima K., Murata T., Tanaka H., Matsuoka T., Sakata D., Yoshida N., et al. Thromboxane A2 modulates interaction of dendritic cells and T cells and regulates acquired immunity. Nat Immunol 4 (2003) 694-701
75. Harenberg A., Girkontaite I., Giehl K., and Fischer K.D. The Lsc rhoGEF mediates signaling from thromboxane A2 to actin polymerization and apoptosis in thymocytes. Eur J Immunol 35 (2005) 1977-1986
76. Kabarowski J.H., Feramisco J.D., Le L.Q., Gu J.L., Luoh S.W., Simon M.I., et al. Direct genetic demonstration of G alpha 13 coupling to the orphan G protein-coupled receptor G2A leading to rhoA-dependent actin rearrangement. Proc Natl Acad Sci USA 97 (2000) 12109-12114
77. Le L.Q., Kabarowski J.H., Weng Z., Satterthwaite A.B., Harvill E.T., Jensen E.R., et al. Mice lacking the orphan G protein-coupled receptor G2A develop a late-onset autoimmune syndrome. Immunity 14 (2001) 561-571
78. Walsh C.T., Stupack D., and Brown J.H. G protein-coupled receptors go extracellular: RhoA integrates the integrins. Mol Interv 8 (2008) 165-173
79. Marrari Y., Crouthamel M., Irannejad R., and Wedegaertner P.B. Assembly and trafficking of heterotrimeric G proteins. Biochemistry 46 (2007) 7665-7677
80. Wettschureck N., Moers A., and Offermanns S. Mouse models to study G-protein-mediated signaling. Pharmacol Ther 101 (2004) 75-89
81. Grant K.R., Harnett W., Milligan G., and Harnett M.M. Differential G-protein expression during B- and T-cell development. Immunology 90 (1997) 564-571
82. Kehrl J.H. G-protein-coupled receptor signaling, RGS proteins, and lymphocyte function. Crit Rev Immunol 24 (2004) 409-423
83. Sunahara R.K., Dessauer C.W., and Gilman A.G. Complexity and diversity of mammalian adenylyl cyclases. Annu Rev Pharmacol Toxicol 36 (1996) 461-480
84. Kaminski N.E., Koh W.S., Yang K.H., Lee M., and Kessler F.K. Suppression of the humoral immune response by cannabinoids is partially mediated through inhibition of adenylate cyclase by a pertussis toxin-sensitive G-protein coupled mechanism. Biochem Pharmacol 48 (1994) 1899-1908
85. Schwindinger W.F., and Robishaw J.D. Heterotrimeric G-protein betagamma-dimers in growth and differentiation. Oncogene 20 (2001) 1653-1660
86. Rudolph U., Finegold M.J., Rich S.S., Harriman G.R., Srinivasan Y., Brabet P., et al. Ulcerative colitis and adenocarcinoma of the colon in G alpha i2-deficient mice. Nat Genet 10 (1995) 143-150
87. Hornquist C.E., Lu X., Rogers-Fani P.M., Rudolph U., Shappell S., Birnbaumer L., et al. G(alpha)i2-deficient mice with colitis exhibit a local increase in memory CD4+ T cells and proinflammatory Th1-type cytokines. J Immunol 158 (1997) 1068-1077
88. He J., Gurunathan S., Iwasaki A., Ash-Shaheed B., and Kelsall B.L. Primary role for Gi protein signaling in the regulation of interleukin 12 production and the induction of T helper cell type 1 responses. J Exp Med 191 (2000) 1605-1610
89. Hou W., Wu Y., Sun S., Shi M., Sun Y., Yang C., et al. Pertussis toxin enhances Th1 responses by stimulation of dendritic cells. J Immunol 170 (2003) 1728-1736
90. Dalwadi H., Wei B., Schrage M., Spicher K., Su T.T., Birnbaumer L., et al. B cell developmental requirement for the G alpha i2 gene. J Immunol 170 (2003) 1707-1715
91. Wilkie T.M., Scherle P.A., Strathmann M.P., Slepak V.Z., and Simon M.I. Characterization of G-protein alpha subunits in the Gq class: expression in murine tissues and in stromal and hematopoietic cell lines. Proc Natl Acad Sci USA 88 (1991) 10049-10053
92. Mapara M.Y., Bommert K., Bargou R.C., Leng C., Beck C., Ludwig W.D., et al. G protein subunit G alpha 16 expression is restricted to progenitor B cells during human B-cell differentiation. Blood 85 (1995) 1836-1842
93. Morton T.L., Ansari M.A., and Jacobson J.D. Gender differences and hormonal modulation of G proteins Galpha(q/11) expression in lymphoid organs. Neuroendocrinology 78 (2003) 147-153
94. Fields T.A., and Casey P.J. Signalling functions and biochemical properties of pertussis toxin-resistant G-proteins. Biochem J 321 Pt. 3 (1997) 561-571
95. Bence K., Ma W., Kozasa T., and Huang X.Y. Direct stimulation of Bruton's tyrosine kinase by G(q)-protein alpha-subunit. Nature 389 (1997) 296-299
96. Nagao M., Yamauchi J., Kaziro Y., and Itoh H. Involvement of protein kinase C and Src family tyrosine kinase in Galphaq/11-induced activation of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase. J Biol Chem 273 (1998) 22892-22898
97. Shi C.S., and Kehrl J.H. PYK2 links G(q)alpha and G(13)alpha signaling to NF-kappa B activation. J Biol Chem 276 (2001) 31845-31850
98. Davignon I., Catalina M.D., Smith D., Montgomery J., Swantek J., Croy J., et al. Normal hematopoiesis and inflammatory responses despite discrete signaling defects in Galpha15 knockout mice. Mol Cell Biol 20 (2000) 797-804
99. Borchers M.T., Justice P.J., Ansay T., Mancino V., McGarry M.P., Crosby J., et al. Gq signaling is required for allergen-induced pulmonary eosinophilia. J Immunol 168 (2002) 3543-3549
100. Shi G., Partida-Sanchez S., Misra R.S., Tighe M., Borchers M.T., Lee J.J., et al. Identification of an alternative G{alpha}q-dependent chemokine receptor signal transduction pathway in dendritic cells and granulocytes. J Exp Med 204 (2007) 2705-2718
101. Yu S., Yu D., Lee E., Eckhaus M., Lee R., Corria Z., et al. Variable and tissue-specific hormone resistance in heterotrimeric Gs protein alpha-subunit (Gsalpha) knockout mice is due to tissue-specific imprinting of the gsalpha gene. Proc Natl Acad Sci USA 95 (1998) 8715-8720
102. Nel A.E., Vandenplas M., Wooten M.M., Cooper R., Vandenplas S., Rheeder A., et al. Cholera toxin partially inhibits the T-cell response to phytohaemagglutinin through the ADP-ribosylation of a 45 kDa membrane protein. Biochem J 256 (1988) 383-390
103. Sommermeyer H., Schwinzer R., Kaever V., and Resch K. Cholera toxin-mediated inhibition of signalling in Jurkat cells is followed by, but not due to a loss of T cell receptor complex. Immunobiology 182 (1991) 266-276
104. Tamir A., Granot Y., and Isakov N. Inhibition of T lymphocyte activation by cAMP is associated with down-regulation of two parallel mitogen-activated protein kinase pathways, the extracellular signal-related kinase and c-Jun N-terminal kinase. J Immunol 157 (1996) 1514-1522
105. Su S.B., Silver P.B., Wang P., Chan C.C., and Caspi R.R. Cholera toxin prevents Th1-mediated autoimmune disease by inducing immune deviation. J Immunol 173 (2004) 755-761
106. Lorenzo J., Horowitz M., and Choi Y. Osteoimmunology: interactions of the bone and immune system. Endocr Rev 29 (2008) 403-440
107. Wu J.Y., Purton L.E., Rodda S.J., Chen M., Weinstein L.S., McMahon A.P., et al. Osteoblastic regulation of B lymphopoiesis is mediated by Gs{alpha}-dependent signaling pathways. Proc Natl Acad Sci USA 105 (2008) 16976-16981
108. Rieken S., Sassmann A., Herroeder S., Wallenwein B., Moers A., Offermanns S., et al. G12/G13 family G proteins regulate marginal zone B cell maturation, migration, and polarization. J Immunol 177 (2006) 2985-2993
109. Xu J., Wang F., Van Keymeulen A., Herzmark P., Straight A., Kelly K., et al. Divergent signals and cytoskeletal assemblies regulate self-organizing polarity in neutrophils. Cell 114 (2003) 201-214
110. Girkontaite I., Missy K., Sakk V., Harenberg A., Tedford K., Potzel T., et al. Lsc is required for marginal zone B cells, regulation of lymphocyte motility and immune responses. Nat Immunol 2 (2001) 855-862
111. Rubtsov A., Strauch P., Digiacomo A., Hu J., Pelanda R., and Torres R.M. Lsc regulates marginal-zone B cell migration and adhesion and is required for the IgM T-dependent antibody response. Immunity 23 (2005) 527-538
112. Francis S.A., Shen X., Young J.B., Kaul P., and Lerner D.J. Rho GEF Lsc is required for normal polarization, migration, and adhesion of formyl-peptide-stimulated neutrophils. Blood 107 (2006) 1627-1635
113. Niu J., Vaiskunaite R., Suzuki N., Kozasa T., Carr D.W., Dulin N., et al. Interaction of heterotrimeric G13 protein with an A-kinase-anchoring protein 110 (AKAP110) mediates cAMP-independent PKA activation. Curr Biol 11 (2001) 1686-1690
114. Jiang Y., Ma W., Wan Y., Kozasa T., Hattori S., and Huang X.Y. The G protein G alpha12 stimulates Bruton's tyrosine kinase and a rasgap through a conserved PH/BM domain. Nature 395 (1998) 808-813
115. Shi C.S., Sinnarajah S., Cho H., Kozasa T., and Kehrl J.H. G13alpha-mediated PYK2 activation. PYK2 is a mediator of g13alpha-induced serum response element-dependent transcription. J Biol Chem 275 (2000) 24470-24476
116. Kozasa T., Jiang X., Hart M.J., Sternweis P.M., Singer W.D., Gilman A.G., et al. P115 rhoGEF, a GTPase activating protein for Galpha12 and Galpha13. Science 280 (1998) 2109-2111
117. Fukuhara S., Chikumi H., and Gutkind J.S. Leukemia-associated Rho guanine nucleotide exchange factor (LARG) links heterotrimeric G proteins of the G(12) family to Rho. FEBS Lett 485 (2000) 183-188
118. Vaiskunaite R., Adarichev V., Furthmayr H., Kozasa T., Gudkov A., and Voyno-Yasenetskaya T.A. Conformational activation of radixin by G13 protein alpha subunit. J Biol Chem 275 (2000) 26206-26212
119. Meigs T.E., Fields T.A., McKee D.D., and Casey P.J. Interaction of Galpha 12 and Galpha 13 with the cytoplasmic domain of cadherin provides a mechanism for beta-catenin release. Proc Natl Acad Sci USA 98 (2001) 519-524
120. Kitamura K., Singer W.D., Star R.A., Muallem S., and Miller R.T. Induction of inducible nitric-oxide synthase by the heterotrimeric G protein Galpha13. J Biol Chem 271 (1996) 7412-7415
121. Coffield V.M., Helms W.S., Jiang Q., and Su L. Galpha13 mediates a signal that is essential for proliferation and survival of thymocyte progenitors. J Exp Med 200 (2004) 1315-1324
122. Worzfeld T., Wettschureck N., and Offermanns S. G(12)/G(13)-mediated signalling in mammalian physiology and disease. Trends Pharmacol Sci 29 (2008) 582-589
123. McIntire W.E., MacCleery G., and Garrison J.C. The G protein beta subunit is a determinant in the coupling of Gs to the beta 1-adrenergic and A2a adenosine receptors. J Biol Chem 276 (2001) 15801-15809
124. Hwang J.I., Fraser I.D., Choi S., Qin X.F., and Simon M.I. Analysis of c5a-mediated chemotaxis by lentiviral delivery of small interfering RNA. Proc Natl Acad Sci USA 101 (2004) 488-493
125. Hwang J.I., Choi S., Fraser I.D., Chang M.S., and Simon M.I. Silencing the expression of multiple Gbeta-subunits eliminates signaling mediated by all four families of G proteins. Proc Natl Acad Sci USA 102 (2005) 9493-9498
126. Chen C.K., Eversole-Cire P., Zhang H., Mancino V., Chen Y.J., He W., et al. Instability of GGL domain-containing RGS proteins in mice lacking the G protein beta-subunit Gbeta5. Proc Natl Acad Sci USA 100 (2003) 6604-6609
127. Schwindinger W.F., Giger K.E., Betz K.S., Stauffer A.M., Sunderlin E.M., Sim-Selley L.J., et al. Mice with deficiency of G protein gamma3 are lean and have seizures. Mol Cell Biol 24 (2004) 7758-7768
128. Schwindinger W.F., Betz K.S., Giger K.E., Sabol A., Bronson S.K., and Robishaw J.D. Loss of G protein gamma 7 alters behavior and reduces striatal alpha(olf) level and cAMP production. J Biol Chem 278 (2003) 6575-6579
129. Shi G.X., Harrison K., Han S.B., Moratz C., and Kehrl J.H. Toll-like receptor signaling alters the expression of regulator of G protein signaling proteins in dendritic cells: implications for G protein-coupled receptor signaling. J Immunol 172 (2004) 5175-5184
130. Reif K., and Cyster J.G. RGS molecule expression in murine B lymphocytes and ability to down-regulate chemotaxis to lymphoid chemokines. J Immunol 164 (2000) 4720-4729
131. Shi G.X., Harrison K., Wilson G.L., Moratz C., and Kehrl J.H. RGS13 regulates germinal center B lymphocytes responsiveness to CXC chemokine ligand (CXCL)12 and CXCL13. J Immunol 169 (2002) 2507-2515
132. Chen C.L., Lin C.F., Chang W.T., Huang W.C., Teng C.F., and Lin Y.S. Ceramide induces p38 MAPK and JNK activation through a mechanism involving a thioredoxin-interacting protein-mediated pathway. Blood 111 (2008) 4365-4374
133. Koren E., Zhou H., Cahaner A., Heller E.D., Pitcovski J., and Lamont S.J. Unique co-expression of immune cell-related genes in IBDV resistant chickens indicates the activation of specific cellular host-response mechanisms. Dev Biol (Basel) 132 (2008) 153-159
134. Hsu H.C., Yang P., Wang J., Wu Q., Myers R., Chen J., et al. Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat Immunol 9 (2008) 166-175
135. -/- mice. Mol Cell Biol 24 (2004) 5767-5775
136. Oliveira-Dos-Santos A.J., Matsumoto G., Snow B.E., Bai D., Houston F.P., Whishaw I.Q., et al. Regulation of T cell activation, anxiety, and male aggression by RGS2. Proc Natl Acad Sci USA 97 (2000) 12272-12277
137. Heximer S.P., Knutsen R.H., Sun X., Kaltenbronn K.M., Rhee M.H., Peng N., et al. Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice. J Clin Invest 111 (2003) 1259
138. Chen C.K., Burns M.E., He W., Wensel T.G., Baylor D.A., and Simon M.I. Slowed recovery of rod photoresponse in mice lacking the gtpase accelerating protein RGS9-1. Nature 403 (2000) 557-560
139. Xie Z., Geiger T.R., Johnson E.N., Nyborg J.K., and Druey K.M. RGS13 acts as a nuclear repressor of CREB. Mol Cell 31 (2008) 660-670
140. Lippert E., Yowe D.L., Gonzalo J.A., Justice J.P., Webster J.M., Fedyk E.R., et al. Role of regulator of G protein signaling 16 in inflammation-induced T lymphocyte migration and activation. J Immunol 171 (2003) 1542-1555
141. Martemyanov K.A., Krispel C.M., Lishko P.V., Burns M.E., and Arshavsky V.Y. Functional comparison of RGS9 splice isoforms in a living cell. Proc Natl Acad Sci USA 105 (2008) 20988-20993
142. Huang X., Fu Y., Charbeneau R.A., Saunders T.L., Taylor D.K., Hankenson K.D., et al. Pleiotropic phenotype of a genomic knock-in of an RGS-insensitive G184S Gnai2 allele. Mol Cell Biol 26 (2006) 6870-6879
143. Martin-McCaffrey L., Willard F.S., Oliveira-dos-Santos A.J., Natale D.R., Snow B.E., Kimple R.J., et al. RGS14 is a mitotic spindle protein essential from the first division of the mammalian zygote. Dev Cell 7 (2004) 763-769
144. http://www.informatics.jax.org/javawi2/servlet/WIFetch?page=alleleDetail &key=35995
145. Han J.I., Huang N.N., Kim D.U., and Kehrl J.H. RGS1 and RGS13 mRNA silencing in a human B lymphoma line enhances responsiveness to chemoattractants and impairs desensitization. J Leukoc Biol 79 (2006) 1357-1368
146. Spangrude G.J., Braaten B.A., and Daynes R.A. Molecular mechanisms of lymphocyte extravasation. I. Studies of two selective inhibitors of lymphocyte recirculation. J Immunol 132 (1984) 354-362
147. Bargatze R.F., and Butcher E.C. Rapid G protein-regulated activation event involved in lymphocyte binding to high endothelial venules. J Exp Med 178 (1993) 367-372
148. Cyster J.G., and Goodnow C.C. Pertussis toxin inhibits migration of B and T lymphocytes into splenic white pulp cords. J Exp Med 182 (1995) 581-586
149. Chaffin K.E., Beals C.R., Wilkie T.M., Forbush K.A., Simon M.I., and Perlmutter R.M. Dissection of thymocyte signaling pathways by in vivo expression of pertussis toxin ADP-ribosyltransferase. EMBO J 9 (1990) 3821-3829
150. Han S.B., Moratz C., Huang N.N., Kelsall B., Cho H., Shi C.S., et al. Rgs1 and Gnai2 regulate the entrance of B lymphocytes into lymph nodes and B cell motility within lymph node follicles. Immunity 22 (2005) 343-354
151. -/- T lymphocytes: implications for T cell movement within lymph nodes. J Immunol 179 (2007) 439-448
152. Sinha R.K., Park C., Hwang I.Y., Davis M.D., and Kehrl J.H. B lymphocytes exit lymph nodes through cortical lymphatic sinusoids near to lymph node follicles by a mechanism independent of S1P-mediated chemotaxis. Immunity 30 (2009) 434-446
153. Bowman E.P., Campbell J.J., Druey K.M., Scheschonka A., Kehrl J.H., and Butcher E.C. Regulation of chemotactic and proadhesive responses to chemoattractant receptors by RGS (regulator of G-protein signaling) family members. J Biol Chem 273 (1998) 28040-28048
154. Agenes F., Bosco N., Mascarell L., Fritah S., and Ceredig R. Differential expression of regulator of G-protein signalling transcripts and in vivo migration of CD4+ naive and regulatory T cells. Immunology 115 (2005) 179-188
155. Fischer U.B., Jacovetty E.L., Medeiros R.B., Goudy B.D., Zell T., Swanson J.B., et al. MHC class II deprivation impairs CD4 T cell motility and responsiveness to antigen-bearing dendritic cells in vivo. Proc Natl Acad Sci USA 104 (2007) 7181-7186
156. Servant G., Weiner O.D., Herzmark P., Balla T., Sedat J.W., and Bourne H.R. Polarization of chemoattractant receptor signaling during neutrophil chemotaxis. Science 287 (2000) 1037-1040
157. Wang F., Herzmark P., Weiner O.D., Srinivasan S., Servant G., and Bourne H.R. Lipid products of PI(3)Ks maintain persistent cell polarity and directed motility in neutrophils. Nat Cell Biol 4 (2002) 513-518
158. Ridley A.J., Schwartz M.A., Burridge K., Firtel R.A., Ginsberg M.H., Borisy G., et al. Cell migration: integrating signals from front to back. Science 302 (2003) 1704-1709
159. Li Z., Dong X., Wang Z., Liu W., Deng N., Ding Y., et al. Regulation of PTEN by Rho small GTPases. Nat Cell Biol 7 (2005) 399-404
160. Okkenhaug K., and Vanhaesebroeck B. PI3K in lymphocyte development, differentiation and activation. Nat Rev Immunol 3 (2003) 317-330
161. Stephens L.R., Eguinoa A., Erdjument-Bromage H., Lui M., Cooke F., Coadwell J., et al. The G beta gamma sensitivity of a PI3K is dependent upon a tightly associated adaptor, p101. Cell 89 (1997) 105-114
162. Suire S., Coadwell J., Ferguson G.J., Davidson K., Hawkins P., and Stephens L. P84, a new Gbetagamma-activated regulatory subunit of the type IB phosphoinositide 3-kinase p110gamma. Curr Biol 15 (2005) 566-570
163. Pacold M.E., Suire S., Perisic O., Lara-Gonzalez S., Davis C.T., Walker E.H., et al. Crystal structure and functional analysis of Ras binding to its effector phosphoinositide 3-kinase gamma. Cell 103 (2000) 931-943
164. Guillermet-Guibert J., Bjorklof K., Salpekar A., Gonella C., Ramadani F., Bilancio A., et al. The p110beta isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110gamma. Proc Natl Acad Sci USA 105 (2008) 8292-8297
165. Hoeller O., and Kay R.R. Chemotaxis in the absence of PIP3 gradients. Curr Biol 17 (2007) 813-817
166. Ferguson G.J., Milne L., Kulkarni S., Sasaki T., Walker S., Andrews S., et al. PI(3)Kgamma has an important context-dependent role in neutrophil chemokinesis. Nat Cell Biol 9 (2007) 86-91
167. Kamimura Y., Xiong Y., Iglesias P.A., Hoeller O., Bolourani P., and Devreotes P.N. PIP3-independent activation of torc2 and PKB at the cell's leading edge mediates chemotaxis. Curr Biol 18 (2008) 1034-1043
168. Heasman S.J., and Ridley A.J. Mammalian Rho GTPases: new insights into their functions from in vivo studies. Nat Rev Mol Cell Biol 9 (2008) 690-701
169. Weiner O.D. Rac activation: P-Rex1-a convergence point for PIP(3) and Gbetagamma?. Curr Biol 12 (2002) R429-R431
170. Srinivasan S., Wang F., Glavas S., Ott A., Hofmann F., Aktories K., et al. Rac and Cdc42 play distinct roles in regulating PI(3,4,5)P3 and polarity during neutrophil chemotaxis. J Cell Biol 160 (2003) 375-385
171. Inoue T., and Meyer T. Synthetic activation of endogenous PI3K and Rac identifies an AND-gate switch for cell polarization and migration. PLoS ONE 3 (2008) e3068
172. Roberts A.W., Kim C., Zhen L., Lowe J.B., Kapur R., Petryniak B., et al. Deficiency of the hematopoietic cell-specific Rho family GTPase Rac2 is characterized by abnormalities in neutrophil function and host defense. Immunity 10 (1999) 183-196
173. Gu Y., Filippi M.D., Cancelas J.A., Siefring J.E., Williams E.P., Jasti A.C., et al. Hematopoietic cell regulation by Rac1 and Rac2 guanosine triphosphatases. Science 302 (2003) 445-449
174. Welch H.C., Coadwell W.J., Ellson C.D., Ferguson G.J., Andrews S.R., Erdjument-Bromage H., et al. P-Rex1, a ptdins(3,4,5)P3- and Gbetagamma-regulated guanine-nucleotide exchange factor for Rac. Cell 108 (2002) 809-821
175. Dong X., Mo Z., Bokoch G., Guo C., Li Z., and Wu D. P-Rex1 is a primary Rac2 guanine nucleotide exchange factor in mouse neutrophils. Curr Biol 15 (2005) 1874-1879
176. Welch H.C., Condliffe A.M., Milne L.J., Ferguson G.J., Hill K., Webb L.M., et al. P-Rex1 regulates neutrophil function. Curr Biol 15 (2005) 1867-1873
177. Gakidis M.A., Cullere X., Olson T., Wilsbacher J.L., Zhang B., Moores S.L., et al. Vav gefs are required for beta2 integrin-dependent functions of neutrophils. J Cell Biol 166 (2004) 273-282
178. Sanui T., Inayoshi A., Noda M., Iwata E., Stein J.V., Sasazuki T., et al. DOCK2 regulates Rac activation and cytoskeletal reorganization through interaction with ELMO1. Blood 102 (2003) 2948-2950
179. Kunisaki Y., Nishikimi A., Tanaka Y., Takii R., Noda M., Inayoshi A., et al. DOCK2 is a Rac activator that regulates motility and polarity during neutrophil chemotaxis. J Cell Biol 174 (2006) 647-652
180. Sai J., Raman D., Liu Y., Wikswo J., and Richmond A. Parallel phosphatidylinositol 3-kinase (PI3K)-dependent and Src-dependent pathways lead to CXCL8-mediated Rac2 activation and chemotaxis. J Biol Chem 283 (2008) 26538-26547
181. Gotoh K., Tanaka Y., Nishikimi A., Inayoshi A., Enjoji M., Takayanagi R., et al. Differential requirement for DOCK2 in migration of plasmacytoid dendritic cells versus myeloid dendritic cells. Blood 111 (2008) 2973-2976
182. Li Z., Hannigan M., Mo Z., Liu B., Lu W., Wu Y., et al. Directional sensing requires G beta gamma-mediated PAK1 and PIX alpha-dependent activation of Cdc42. Cell 114 (2003) 215-227
183. Yoshii S., Tanaka M., Otsuki Y., Wang D.Y., Guo R.J., Zhu Y., et al. Alphapix nucleotide exchange factor is activated by interaction with phosphatidylinositol 3-kinase. Oncogene 18 (1999) 5680-5690
184. Scott R.F. Semin Cell Dev Biol 19 (2008) 234-244
185. Mazaki Y., Hashimoto S., Tsujimura T., Morishige M., Hashimoto A., Aritake K., et al. Neutrophil direction sensing and superoxide production linked by the GTPase-activating protein GIT2. Nat Immunol 7 (2006) 724-731
186. Wong K., Pertz O., Hahn K., and Bourne H. Neutrophil polarization: spatiotemporal dynamics of rhoA activity support a self-organizing mechanism. Proc Natl Acad Sci USA 103 (2006) 3639-3644
187. Amano M., Ito M., Kimura K., Fukata Y., Chihara K., Nakano T., et al. Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem 271 (1996) 20246-20249
188. Lee H.H., and Chang Z.F. Regulation of rhoA-dependent ROCKII activation by Shp2. J Cell Biol 181 (2008) 999-1012
189. Lacalle R.A., Gomez-Mouton C., Barber D.F., Jimenez-Baranda S., Mira E., Martinez A.C., et al. PTEN regulates motility but not directionality during leukocyte chemotaxis. J Cell Sci 117 (2004) 6207-6215
190. Nishio M., Watanabe K., Sasaki J., Taya C., Takasuga S., Iizuka R., et al. Control of cell polarity and motility by the ptdins(3,4,5)P3 phosphatase SHIP1. Nat Cell Biol 9 (2007) 36-44
191. Gardiner E.M., Pestonjamasp K.N., Bohl B.P., Chamberlain C., Hahn K.M., and Bokoch G.M. Spatial and temporal analysis of Rac activation during live neutrophil chemotaxis. Curr Biol 12 (2002) 2029-2034
192. Van Keymeulen A., Wong K., Knight Z.A., Govaerts C., Hahn K.M., Shokat K.M., et al. To stabilize neutrophil polarity, PIP3 and Cdc42 augment rhoA activity at the back as well as signals at the front. J Cell Biol 174 (2006) 437-445
193. Pestonjamasp K.N., Forster C., Sun C., Gardiner E.M., Bohl B., Weiner O., et al. Rac1 links leading edge and uropod events through Rho and myosin activation during chemotaxis. Blood 108 (2006) 2814-2820
194. Lacalle R.A., Peregil R.M., Albar J.P., Merino E., Martinez A.C., Merida I., et al. Type I phosphatidylinositol 4-phosphate 5-kinase controls neutrophil polarity and directional movement. J Cell Biol 179 (2007) 1539-1553
195. Chen S., Lin F., Shin M.E., Wang F., Shen L., and Hamm H.E. RACK1 regulates directional cell migration by acting on G betagamma at the interface with its effectors PLC beta and PI3K gamma. Mol Biol Cell 19 (2008) 3909-3922
196. Ghosh P., Garcia-Marcos M., Bornheimer S.J., and Farquhar M.G. Activation of Galphai3 triggers cell migration via regulation of GIV. J Cell Biol 182 (2008) 381-393
197. Kashef K., Lee C.M., Ha J.H., Reddy E.P., and Dhanasekaran D.N. JNK-interacting leucine zipper protein is a novel scaffolding protein in the Galpha13 signaling pathway. Biochemistry 44 (2005) 14090-14096
198. Gantulga D., Tuvshintugs B., Endo Y., Takino T., Sato H., Murakami S., et al. The scaffold protein c-Jun NH2-terminal kinase-associated leucine zipper protein regulates cell migration through interaction with the G protein G{alpha}13. J Biochem 144 (2008) 693-700
199. Li Z., Jiang H., Xie W., Zhang Z., Smrcka A.V., and Wu D. Roles of PLC-beta2 and -beta3 and PI3Kgamma in chemoattractant-mediated signal transduction. Science 287 (2000) 1046-1049
200. Sasaki T., Irie-Sasaki J., Jones R.G., Oliveira-dos-Santos A.J., Stanford W.L., Bolon B., et al. Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration. Science 287 (2000) 1040-1046
201. Hirsch E., Katanaev V.L., Garlanda C., Azzolino O., Pirola L., Silengo L., et al. Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science 287 (2000) 1049-1053
202. Reif K., Okkenhaug K., Sasaki T., Penninger J.M., Vanhaesebroeck B., and Cyster J.G. Cutting edge: differential roles for phosphoinositide 3-kinases, p110gamma and p110delta, in lymphocyte chemotaxis and homing. J Immunol 173 (2004) 2236-2240
203. Martin A.L., Schwartz M.D., Jameson S.C., and Shimizu Y. Selective regulation of CD8 effector T cell migration by the p110 gamma isoform of phosphatidylinositol 3-kinase. J Immunol 180 (2008) 2081-2088
204. Ortolano S., Hwang I.Y., Han S.B., and Kehrl J.H. Roles for phosphoinositide 3-kinases, Bruton's tyrosine kinase, and Jun kinases in B lymphocyte chemotaxis and homing. Eur J Immunol 36 (2006) 1285-1295
205. Jarmin S.J., David R., Ma L., Chai J.G., Dewchand H., Takesono A., et al. T cell receptor-induced phosphoinositide-3-kinase p110delta activity is required for T cell localization to antigenic tissue in mice. J Clin Invest 118 (2008) 1154-1164
206. Ji H., Rintelen F., Waltzinger C., Bertschy Meier D., Bilancio A., Pearce W., et al. Inactivation of PI3Kgamma and PI3Kdelta distorts T-cell development and causes multiple organ inflammation. Blood 110 (2007) 2940-2947
207. Sinclair L.V., Finlay D., Feijoo C., Cornish G.H., Gray A., Ager A., et al. Phosphatidylinositol-3-OH kinase and nutrient-sensing mtor pathways control T lymphocyte trafficking. Nat Immunol 9 (2008) 513-521
208. Fukui Y., Hashimoto O., Sanui T., Oono T., Koga H., Abe M., et al. Haematopoietic cell-specific CDM family protein DOCK2 is essential for lymphocyte migration. Nature 412 (2001) 826-831
209. Nombela-Arrieta C., Lacalle R.A., Montoya M.C., Kunisaki Y., Megias D., Marques M., et al. Differential requirements for DOCK2 and phosphoinositide-3-kinase gamma during T and B lymphocyte homing. Immunity 21 (2004) 429-441
210. Shulman Z., Pasvolsky R., Woolf E., Grabovsky V., Feigelson S.W., Erez N., et al. DOCK2 regulates chemokine-triggered lateral lymphocyte motility but not transendothelial migration. Blood 108 (2006) 2150-2158
211. Nombela-Arrieta C., Mempel T.R., Soriano S.F., Mazo I., Wymann M.P., Hirsch E., et al. A central role for DOCK2 during interstitial lymphocyte motility and sphingosine-1-phosphate-mediated egress. J Exp Med 204 (2007) 497-510
212. Takesono A., Horai R., Mandai M., Dombroski D., and Schwartzberg P.L. Requirement for Tec kinases in chemokine-induced migration and activation of Cdc42 and Rac. Curr Biol 14 (2004) 917-922
213. Cote J.F., Motoyama A.B., Bush J.A., and Vuori K. A novel and evolutionarily conserved ptdins(3,4,5)P3-binding domain is necessary for DOCK180 signalling. Nat Cell Biol 7 (2005) 797-807
214. Vicente-Manzanares M., Cruz-Adalia A., Martin-Cofreces N.B., Cabrero J.R., Dosil M., Alvarado-Sanchez B., et al. Control of lymphocyte shape and the chemotactic response by the GTP exchange factor Vav. Blood 105 (2005) 3026-3034
215. Croker B.A., Tarlinton D.M., Cluse L.A., Tuxen A.J., Light A., Yang F.C., et al. The Rac2 guanosine triphosphatase regulates B lymphocyte antigen receptor responses and chemotaxis and is required for establishment of B-1a and marginal zone B lymphocytes. J Immunol 168 (2002) 3376-3386
216. Haddad E., Zugaza J.L., Louache F., Debili N., Crouin C., Schwarz K., et al. The interaction between Cdc42 and WASP is required for SDF-1-induced T-lymphocyte chemotaxis. Blood 97 (2001) 33-38
217. Missy K., Hu B., Schilling K., Harenberg A., Sakk V., Kuchenbecker K., et al. Alphapix Rho GTPase guanine nucleotide exchange factor regulates lymphocyte functions and antigen receptor signaling. Mol Cell Biol 28 (2008) 3776-3789
218. Giagulli C., Scarpini E., Ottoboni L., Narumiya S., Butcher E.C., Constantin G., et al. Rhoa and zeta PKC control distinct modalities of LFA-1 activation by chemokines: critical role of LFA-1 affinity triggering in lymphocyte in vivo homing. Immunity 20 (2004) 25-35
219. Tan W., Martin D., and Gutkind J.S. The Galpha13-Rho signaling axis is required for SDF-1-induced migration through CXCR4. J Biol Chem 281 (2006) 39542-39549
220. Lee J.H., Katakai T., Hara T., Gonda H., Sugai M., and Shimizu A. Roles of p-ERM and Rho-ROCK signaling in lymphocyte polarity and uropod formation. J Cell Biol 167 (2004) 327-337
221. Bardi G., Niggli V., and Loetscher P. Rho kinase is required for CCR7-mediated polarization and chemotaxis of T lymphocytes. FEBS Lett 542 (2003) 79-83
222. Samaniego R., Sanchez-Martin L., Estecha A., and Sanchez-Mateos P. Rho/ROCK and myosin II control the polarized distribution of endocytic clathrin structures at the uropod of moving T lymphocytes. J Cell Sci 120 (2007) 3534-3543
223. Vicente-Manzanares M., Rey M., Perez-Martinez M., Yanez-Mo M., Sancho D., Cabrero J.R., et al. The rhoA effector mDia is induced during T cell activation and regulates actin polymerization and cell migration in T lymphocytes. J Immunol 171 (2003) 1023-1034
224. Kinashi T., and Katagiri K. Regulation of immune cell adhesion and migration by regulator of adhesion and cell polarization enriched in lymphoid tissues. Immunology 116 (2005) 164-171
225. Shimonaka M., Katagiri K., Nakayama T., Fujita N., Tsuruo T., Yoshie O., et al. Rap1 translates chemokine signals to integrin activation, cell polarization, and motility across vascular endothelium under flow. J Cell Biol 161 (2003) 417-427
226. Katagiri K., Ohnishi N., Kabashima K., Iyoda T., Takeda N., Shinkai Y., et al. Crucial functions of the Rap1 effector molecule RAPL in lymphocyte and dendritic cell trafficking. Nat Immunol 5 (2004) 1045-1051
227. Chu H., Awasthi A., White II G.C., Chrzanowska-Wodnicka M., and Malarkannan S. Rap1b regulates B cell development, homing, and T cell-dependent humoral immunity. J Immunol 181 (2008) 3373-3383
228. Chen Y., Yu M., Podd A., Wen R., Chrzanowska-Wodnicka M., White G.C., et al. A critical role of Rap1b in B-cell trafficking and marginal zone B-cell development. Blood 111 (2008) 4627-4636
229. Li Y., Yan J., De P., Chang H.C., Yamauchi A., Christopherson II K.W., et al. Rap1a null mice have altered myeloid cell functions suggesting distinct roles for the closely related Rap1a and 1b proteins. J Immunol 179 (2007) 8322-8331
230. Gerard A., Mertens A.E., van der Kammen R.A., and Collard J.G. The Par polarity complex regulates Rap1- and chemokine-induced T cell polarization. J Cell Biol 176 (2007) 863-875
231. de Gorter D.J., Reijmers R.M., Beuling E.A., Naber H.P., Kuil A., Kersten M.J., et al. The small GTPase Ral mediates SDF-1-induced migration of B cells and multiple myeloma cells. Blood 111 (2008) 3364-3372
232. Inngjerdingen M., Torgersen K.M., and Maghazachi A.A. Lck is required for stromal cell-derived factor 1 alpha (CXCL12)-induced lymphoid cell chemotaxis. Blood 99 (2002) 4318-4325
233. Park D., Park I., Lee D., Choi Y.B., Lee H., and Yun Y. The adaptor protein Lad associates with the G protein beta subunit and mediates chemokine-dependent T-cell migration. Blood 109 (2007) 5122-5128
234. Okabe S., Fukuda S., Kim Y.J., Niki M., Pelus L.M., Ohyashiki K., et al. Stromal cell-derived factor-1alpha/CXCL12-induced chemotaxis of T cells involves activation of the rasGAP-associated docking protein p62Dok-1. Blood 105 (2005) 474-480
235. de Gorter D.J., Beuling E.A., Kersseboom R., Middendorp S., van Gils J.M., Hendriks R.W., et al. Bruton's tyrosine kinase and phospholipase Cgamma2 mediate chemokine-controlled B cell migration and homing. Immunity 26 (2007) 93-104
236. Jiang H., Kuang Y., Wu Y., Xie W., Simon M.I., and Wu D. Roles of phospholipase C beta2 in chemoattractant-elicited responses. Proc Natl Acad Sci USA 94 (1997) 7971-7975
237. Jin T., and Hereld D. Moving toward understanding eukaryotic chemotaxis. Eur J Cell Biol 85 (2006) 905-913
238. Jin T., Zhang N., Long Y., Parent C.A., and Devreotes P.N. Localization of the G protein betagamma complex in living cells during chemotaxis. Science 287 (2000) 1034-1036
239. Xu X., Meier-Schellersheim M., Jiao X., Nelson L.E., and Jin T. Quantitative imaging of single live cells reveals spatiotemporal dynamics of multistep signaling events of chemoattractant gradient sensing in Dictyostelium. Mol Biol Cell 16 (2005) 676-688
240. Xu X., Meier-Schellersheim M., Yan J., and Jin T. Locally controlled inhibitory mechanisms are involved in eukaryotic GPCR-mediated chemosensing. J Cell Biol 178 (2007) 141-153
241. Sullivan S.J., Daukas G., and Zigmond S.H. Asymmetric distribution of the chemotactic peptide receptor on polymorphonuclear leukocytes. J Cell Biol 99 (1984) 1461-1467
242. Nieto M., Frade J.M., Sancho D., Mellado M., Martinez A.C., and Sanchez-Madrid F. Polarization of chemokine receptors to the leading edge during lymphocyte chemotaxis. J Exp Med 186 (1997) 153-158
243. van Buul J.D., Voermans C., van Gelderen J., Anthony E.C., van der Schoot C.E., and Hordijk P.L. Leukocyte-endothelium interaction promotes SDF-1-dependent polarization of CXCR4. J Biol Chem 278 (2003) 30302-30310
244. Gomez-Mouton C., Lacalle R.A., Mira E., Jimenez-Baranda S., Barber D.F., Carrera A.C., et al. Dynamic redistribution of raft domains as an organizing platform for signaling during cell chemotaxis. J Cell Biol 164 (2004) 759-768
245. Servant G., Weiner O.D., Neptune E.R., Sedat J.W., and Bourne H.R. Dynamics of a chemoattractant receptor in living neutrophils during chemotaxis. Mol Biol Cell 10 (1999) 1163-1178
246. Manes S., Mira E., Gomez-Mouton C., Lacalle R.A., Keller P., Labrador J.P., et al. Membrane raft microdomains mediate front-rear polarity in migrating cells. EMBO J 18 (1999) 6211-6220
247. Gomez-Mouton C., Abad J.L., Mira E., Lacalle R.A., Gallardo E., Jimenez-Baranda S., et al. Segregation of leading-edge and uropod components into specific lipid rafts during T cell polarization. Proc Natl Acad Sci USA 98 (2001) 9642-9647
248. Kunwar P.S., Sano H., Renault A.D., Barbosa V., Fuse N., and Lehmann R. Tre1 GPCR initiates germ cell transepithelial migration by regulating Drosophila melanogaster E-cadherin. J Cell Biol 183 (2008) 157-168
249. Wong K., Van Keymeulen A., and Bourne H.R. PDZRhoGEF and myosin II localize rhoA activity to the back of polarizing neutrophil-like cells. J Cell Biol 179 (2007) 1141-1148
250. Hu J., Strauch P., Rubtsov A., Donovan E.E., Pelanda R., and Torres R.M. Lsc activity is controlled by oligomerization and regulates integrin adhesion. Mol Immunol 45 (2008) 1825-1836
251. Belluscio L., Gold G.H., Nemes A., and Axel R. Mice deficient in G(olf) are anosmic. Neuron 20 (1998) 69-81
252. (-/-) mice is an intrinsic naive CD4(+) T cell disorder selective for the Galphai2 subunit. Int Immunol 15 (2003) 1359-1367
253. Jiang M., Gold M.S., Boulay G., Spicher K., Peyton M., Brabet P., et al. Multiple neurological abnormalities in mice deficient in the G protein Go. Proc Natl Acad Sci USA 95 (1998) 3269-3274
254. Yang J., Wu J., Kowalska M.A., Dalvi A., Prevost N., O'Brien P.J., et al. Loss of signaling through the G protein, Gz, results in abnormal platelet activation and altered responses to psychoactive drugs. Proc Natl Acad Sci USA 97 (2000) 9984-9989
255. Hendry I.A., Kelleher K.L., Bartlett S.E., Leck K.J., Reynolds A.J., Heydon K., et al. Hypertolerance to morphine in G(z alpha)-deficient mice. Brain Res 870 (2000) 10-19
256. Calvert P.D., Krasnoperova N.V., Lyubarsky A.L., Isayama T., Nicolo M., Kosaras B., et al. Phototransduction in transgenic mice after targeted deletion of the rod transducin alpha-subunit. Proc Natl Acad Sci USA 97 (2000) 13913-13918
257. Wong G.T., Gannon K.S., and Margolskee R.F. Transduction of bitter and sweet taste by gustducin. Nature 381 (1996) 796-800
258. Offermanns S., Hashimoto K., Watanabe M., Sun W., Kurihara H., Thompson R.F., et al. Impaired motor coordination and persistent multiple climbing fiber innervation of cerebellar Purkinje cells in mice lacking Galphaq. Proc Natl Acad Sci USA 94 (1997) 14089-14094
259. Offermanns S., Toombs C.F., Hu Y.H., and Simon M.I. Defective platelet activation in G alpha(q)-deficient mice. Nature 389 (1997) 183-186
260. Offermanns S., Zhao L.P., Gohla A., Sarosi I., Simon M.I., and Wilkie T.M. Embryonic cardiomyocyte hypoplasia and craniofacial defects in G alpha q/G alpha 11-mutant mice. EMBO J 17 (1998) 4304-4312
261. Gu J.L., Muller S., Mancino V., Offermanns S., and Simon M.I. Interaction of G alpha(12) with G alpha(13) and G alpha(q) signaling pathways. Proc Natl Acad Sci USA 99 (2002) 9352-9357
262. Offermanns S., Mancino V., Revel J.P., and Simon M.I. Vascular system defects and impaired cell chemokinesis as a result of Galpha13 deficiency. Science 275 (1997) 533-536
263. Moers A., Nieswandt B., Massberg S., Wettschureck N., Gruner S., Konrad I., et al. G13 is an essential mediator of platelet activation in hemostasis and thrombosis. Nat Med 9 (2003) 1418-1422
264. -/- mice. J Neurosci 23 (2003) 6965-6971
265. Takimoto E., Koitabashi N., Hsu S., Ketner E.A., Zhang M., Nagayama T., et al. Regulator of G protein signaling 2 mediates cardiac compensation to pressure overload and antihypertrophic effects of PDE5 inhibition in mice. J Clin Invest 119 (2009) 408-420
266. Grillet N., Pattyn A., Contet C., Kieffer B.L., Goridis C., and Brunet J.F. Generation and characterization of Rgs4 mutant mice. Mol Cell Biol 25 (2005) 4221-4228
267. Cifelli C., Rose R.A., Zhang H., Voigtlaender-Bolz J., Bolz S.S., Backx P.H., et al. RGS4 regulates parasympathetic signaling and heart rate control in the sinoatrial node. Circ Res 103 (2008) 527-535
268. Hamzah J., Jugold M., Kiessling F., Rigby P., Manzur M., Marti H.H., et al. Vascular normalization in Rgs5-deficient tumours promotes immune destruction. Nature 453 (2008) 410-414
269. Cho H., Park C., Hwang I.Y., Han S.B., Schimel D., Despres D., et al. Rgs5 targeting leads to chronic low blood pressure and a lean body habitus. Mol Cell Biol 28 (2008) 2590-2597
270. Nisancioglu M.H., Mahoney Jr. W.M., Kimmel D.D., Schwartz S.M., Betsholtz C., and Genove G. Generation and characterization of rgs5 mutant mice. Mol Cell Biol 28 (2008) 2324-2331
271. http://www.informatics.jax.org/javawi2/servlet/WIFetch?page=alleleDetail &key=35996
272. Kovoor A., Seyffarth P., Ebert J., Barghshoon S., Chen C.K., Schwarz S., et al. D2 dopamine receptors colocalize regulator of G-protein signaling 9-2 (RGS9-2) via the RGS9 DEP domain, and RGS9 knock-out mice develop dyskinesias associated with dopamine pathways. J Neurosci 25 (2005) 2157-2165
273. Blundell J., Hoang C.V., Potts B., Gold S.J., and Powell C.M. Motor coordination deficits in mice lacking RGS9. Brain Res 1190 (2008) 78-85
274. http://www.informatics.jax.org/javawi2/servlet/WIFetch?page=alleleDetail &key=36672
275. Yang S., and Li Y.P. RGS10-null mutation impairs osteoclast differentiation resulting from the loss of [Ca2+]i oscillation regulation. Genes Dev 21 (2007) 1803-1816
276. http://www.informatics.jax.org/javawi2/servlet/WIFetch?page=alleleDetail &key=35988
277. Bansal G., Xie Z., Rao S., Nocka K.H., and Druey K.M. Suppression of immunoglobulin E-mediated allergic responses by regulator of G protein signaling 13. Nat Immunol 9 (2008) 73-80